Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection in China

NCT01844310 is registered in ClinicalTrials.gov with Peking Union Medical College as lead sponsor.

NCT NCT01844310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01844310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection in China
Lead sponsor
Peking Union Medical College
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2013
Completion date
December 31, 2015
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aids/hiv problem